Decisions about add-on reimbursement for medical devices in France in September 2019

28

Oct 2019

The French National Authority for Health (HAS) released new decisions about add-on and medical aid reimbursement of many medical devices from the meetings of the National Commission for Evaluation of Medical Devices and Health Technologies (CNEDiMTS) in September 2019.

One (1) decision was released regarding orthopedic devices:

  • DAC, bioabsorbable hydrogel for orthopedic implants (application for registration, rejected because the provided data do not establish the interest)

Eight (8) decisions were released for cardiovascular devices:

  • iVASCULAR LUMINOR 18 and 35, paclitaxel-eluting balloon (application for registration, approved)
  • COMBO PLUS Stent, coronary stent with sirolimus release (pharmacologically active product) with bioabsorbable matrix coated with anti-CD34 monoclonal antibodies (application for registration, rejected because the provided data do not establish the interest)
  • BIOMONITOR 2-AF, implantable cardiac monitor with remote monitoring (application for registration, approved)
  • COMBO Stent, coronary stent with sirolimus release (pharmacologically active product) with bioabsorbable matrix coated with anti-CD34 monoclonal antibodies (application for registration, rejected because the provided data do not establish the interest)
  • CONFIRM RX model DM3500, implantable cardiac monitor (application for registration, approved)
  • LIFEVEST 4000, portable external cardiac defibrillator (application to change the registration conditions, approved)
  • BIOMIME, coronary stent (stent) coated with sirolimus (pharmacologically active product) (application for registration, rejected because the provided data do not establish the interest)
  • ZENITH Universal Distal Body, stent (application for registration, approved)

NIne (9) decisions were released for other devices:

  • CHORUS, sound processor for cochlear implant system (application for registration, approved)
  • NUCLEUS CI612, CI622, and CI632, cochlear implants (application for registration, approved)
  • POUSSEUR2 PREMIUM, electric motor propulsion device controlled only by the accompanying person (application for registration, approved)
  • VTP SYSTEM FOR TOOKAD, consisting of the TOO-DIFFUSER light-diffusing optical fiber, the TOO-PROBE isotropic rectal probe optical fiber, the TOO-CATH S metal end introducer catheter and the TOO-CATH smooth end introducer catheter (application for registration, rejected because the provided data do not establish the interest)
  • LYRIC3, permanent-wear in-ear hearing aid (application for registration, rejected because the provided data do not establish the interest)
  • TOPCHAIR-S, electric wheelchair climber (renewal of registration, approved)
  • PERISTEEN OBTAL, analog obturator tampon (renewal of registration, approved)
  • INFASOURCE, foodstuff for special medical purposes for oral and enteral nutrition (application for registration, approved)

See the list of decisions in French here.

Subscribe to our newsletter delivered every second week not to miss important reimbursement information.

The latest related news

24

Mar 2022

The HTA body of the Tuscany Regional Healthcare issues two types of documents: HTA forms and motivational forms. With a regional decree 2472 of February 10, 2022, Tuscany Regional Healthcare has published assessments of five medical devices of various therapeutic areas, such as cardiovascular and peripheral vascular areas.

Read more

18

Mar 2022

On February 22, 2022, a repository of innovative acts outside the nomenclature of biology and anatomopathology (RIHN) and a Supplementary list of IVD tests were published. Minor changes were introduced in the 2022 RIHN list.

Read more

14

Mar 2022

In February 2021, the Clinical Coding and Schedule Development (CCSD) working group, which develops and maintains procedural and diagnostics nomenclature for private payers in England, published Bulletins 0182 and 0079 with changes to be implemented no later than April 10, 2022. Three new procedure codes concerned robotic surgery in orthopaedic area, spinal procedures, and ophthalmology, and five new diagnostic codes were introduced.

Read more

11

Mar 2022

On February 07, 2022, the Dental and Pharmaceutical Benefits Agency has announced the withdrawal of the assessments of the PhysioMem PM 100 and CardioMem CM 100 XT and the finalization of the assessments of the Zenicor ECG, Coala Heart Monitor Pro, and KardiaMobile. For the conducted assessments, it was outlined that the portable devices provide more limited information than standard ECG measurements; therefore, it was mainly estimated for atrial fibrillation.

Read more

08

Mar 2022

At the end of February 2022, the Dental and Pharmaceutical Benefits Agency (TLV) has launched a theme survey on products for monitoring and diagnostics of sepsis to identify products that may be relevant for health economic assessments at TLV. The suggestions for the products of interest, ongoing clinical studies, or innovation projects could be received until 23 March 2022.

Read more